Visualitza per autor "Moltó Abad, Marc Miquel"
Ara mostrant els elements 1-3 d 3
-
Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II): a new tool for evidence-based medicine in rare diseases
Miguel-Huguet, Bernat; Pardo-Mateos, Almudena; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Moltó Abad, Marc Miquel; Pérez López, Jorge; Sampayo-Cordero, Miguel; Malfettone, Andrea (Springer Nature, 2019-10-21) -
Biomarkers in Fabry Disease: Implications for Clinical Diagnosis and Follow-up
Carnicer Cáceres, Clara; Arranz Amo, José Antonio; Cea Arestín, Cristina; Camprodon Gomez, Maria; Moreno Martinez, David; Lucas del Pozo, Sara; Moltó Abad, Marc Miquel; Tigri-Santiña, Ariadna; Agraz Pamplona, Irene; Hernández Vara, Jorge; Armengol Bellapart, Mar; del Toro Riera, Mireia; Pintos Morell, Guillem; Rodríguez Palomares, Jose Fernando (MDPI, 2021-04-13) -
Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience
Quijada‑Fraile, Pilar; Arranz Canales, Elena; Martín‑Hernández, Elena; Ballesta‑Martínez, María Juliana; Guillén‑Navarro, Encarna; Pintos Morell, Guillem; Moltó Abad, Marc Miquel; Moreno Martinez, David (BMC, 2021-11-03)